tumors; adjacent normal tissues
RKO; SW620
cell line-derived xenograft
proliferation (promotes); apoptosis (inhibits); cell cycle (other); other pathway/process (other)
Microarray; RT-qPCR; Clinical Sample Validation; Transfection; MTT; Annexin V/PI Flow Cytometry; Cell Cycle Assay; In Vivo Animal Model
may be a potential biomarker for early diagnosis or prognosis of CRC and a novel drug target for CRC therapy
hsa_circ_0064559 is up-regulated in colorectal cancer. Its knockdown suppresses CRC cell proliferation, increases apoptosis and G1-phase accumulation in vitro, and inhibits tumor growth in a nude-mouse xenograft model, accompanied by broad changes in apoptosis/proliferation-related gene expression (e.g., STAT1, BAX, CD274).
0.5802
Circular RNA hsa_circ_0064559 affects tumor cell growth and progression of colorectal cancer.
combined biological and clinical study